1m6t › Citations

Redesign of a four-helix bundle protein by phage display coupled with proteolysis and structural characterization by NMR and X-ray crystallography.

Chu R, Takei J, Knowlton JR, Andrykovitch M, Pei W, Kajava AV, Steinbach PJ, Ji X, Bai Y
J Mol Biol 323 253-62 (2002)
Cited: 74 times
EuropePMC logo PMID: 12381319

Abstract

To test whether it is practical to use phage display coupled with proteolysis for protein design, we used this approach to convert a partially unfolded four-helix bundle protein, apocytochrome b(562), to a stably folded four-helix bundle protein. Four residues expected to form a hydrophobic core were mutated. One residue was changed to Trp to provide a fluorescence probe for studying the protein's physical properties and to partially fill the void left by the heme. The other three positions were randomly mutated. In addition, another residue in the region to be redesigned was substituted with Arg to provide a specific cutting site for protease Arg-c. This library of mutants was displayed on the surface of phage and challenged with protease Arg-c to select stably folded proteins. The consensus sequence that emerged from the selection included hydrophobic residues at only one of the three positions and non-hydrophobic residues at the other two. Nevertheless, the selected proteins were thermodynamically very stable. The structure of a selected protein was characterized using multi-dimensional NMR. All four helices were formed in the structure. Further, site-directed mutagenesis was used to change one of the two non-hydrophobic residues to a hydrophobic residue, which increased the stability of the protein, indicating that the selection result was not based solely on the protein's global stability and that local structural characteristics may also govern the selection. This conclusion is supported by the crystal structure of another mutant that has two hydrophobic residues substituted for the two non-hydrophobic residues. These results suggest that the hydrophobic interactions in the core are not sufficient to dictate the selection and that the location of the cutting site of the protease also influences the selection of structures.

Reviews - 1m6t mentioned but not cited (3)

  1. Protein scaffold-based molecular probes for cancer molecular imaging. Miao Z, Levi J, Cheng Z. Amino Acids 41 1037-1047 (2011)
  2. Structural gymnastics of multifunctional metamorphic proteins. Goodchild SC, Curmi PMG, Brown LJ. Biophys Rev 3 143 (2011)
  3. X-ray crystallography of TRP channels. Singh AK, McGoldrick LL, Saotome K, Sobolevsky AI. Channels (Austin) 12 137-152 (2018)

Articles - 1m6t mentioned but not cited (33)

  1. Structure of the human glucagon class B G-protein-coupled receptor. Siu FY, He M, de Graaf C, Han GW, Yang D, Zhang Z, Zhou C, Xu Q, Wacker D, Joseph JS, Liu W, Lau J, Cherezov V, Katritch V, Wang MW, Stevens RC. Nature 499 444-449 (2013)
  2. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Chun E, Thompson AA, Liu W, Roth CB, Griffith MT, Katritch V, Kunken J, Xu F, Cherezov V, Hanson MA, Stevens RC. Structure 20 967-976 (2012)
  3. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Zhang K, Zhang J, Gao ZG, Zhang D, Zhu L, Han GW, Moss SM, Paoletta S, Kiselev E, Lu W, Fenalti G, Zhang W, Müller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q. Nature 509 115-118 (2014)
  4. Crystal Structure of an LSD-Bound Human Serotonin Receptor. Wacker D, Wang S, McCorvy JD, Betz RM, Venkatakrishnan AJ, Levit A, Lansu K, Schools ZL, Che T, Nichols DE, Shoichet BK, Dror RO, Roth BL. Cell 168 377-389.e12 (2017)
  5. Two disparate ligand-binding sites in the human P2Y1 receptor. Zhang D, Gao ZG, Zhang K, Kiselev E, Crane S, Wang J, Paoletta S, Yi C, Ma L, Zhang W, Han GW, Liu H, Cherezov V, Katritch V, Jiang H, Stevens RC, Jacobson KA, Zhao Q, Wu B. Nature 520 317-321 (2015)
  6. Agonist-bound structure of the human P2Y12 receptor. Zhang J, Zhang K, Gao ZG, Paoletta S, Zhang D, Han GW, Li T, Ma L, Zhang W, Müller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q. Nature 509 119-122 (2014)
  7. Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Che T, Majumdar S, Zaidi SA, Ondachi P, McCorvy JD, Wang S, Mosier PD, Uprety R, Vardy E, Krumm BE, Han GW, Lee MY, Pardon E, Steyaert J, Huang XP, Strachan RT, Tribo AR, Pasternak GW, Carroll FI, Stevens RC, Cherezov V, Katritch V, Wacker D, Roth BL. Cell 172 55-67.e15 (2018)
  8. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Xu K, Acharya P, Kong R, Cheng C, Chuang GY, Liu K, Louder MK, O'Dell S, Rawi R, Sastry M, Shen CH, Zhang B, Zhou T, Asokan M, Bailer RT, Chambers M, Chen X, Choi CW, Dandey VP, Doria-Rose NA, Druz A, Eng ET, Farney SK, Foulds KE, Geng H, Georgiev IS, Gorman J, Hill KR, Jafari AJ, Kwon YD, Lai YT, Lemmin T, McKee K, Ohr TY, Ou L, Peng D, Rowshan AP, Sheng Z, Todd JP, Tsybovsky Y, Viox EG, Wang Y, Wei H, Yang Y, Zhou AF, Chen R, Yang L, Scorpio DG, McDermott AB, Shapiro L, Carragher B, Potter CS, Mascola JR, Kwong PD. Nat Med 24 857-867 (2018)
  9. XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity. Johansson LC, Stauch B, McCorvy JD, Han GW, Patel N, Huang XP, Batyuk A, Gati C, Slocum ST, Li C, Grandner JM, Hao S, Olsen RHJ, Tribo AR, Zaare S, Zhu L, Zatsepin NA, Weierstall U, Yous S, Stevens RC, Liu W, Roth BL, Katritch V, Cherezov V. Nature 569 289-292 (2019)
  10. Nanobody-enabled monitoring of kappa opioid receptor states. Che T, English J, Krumm BE, Kim K, Pardon E, Olsen RHJ, Wang S, Zhang S, Diberto JF, Sciaky N, Carroll FI, Steyaert J, Wacker D, Roth BL. Nat Commun 11 1145 (2020)
  11. X-ray structures of the high-affinity copper transporter Ctr1. Ren F, Logeman BL, Zhang X, Liu Y, Thiele DJ, Yuan P. Nat Commun 10 1386 (2019)
  12. Structural basis of ligand binding modes at the human formyl peptide receptor 2. Chen T, Xiong M, Zong X, Ge Y, Zhang H, Wang M, Won Han G, Yi C, Ma L, Ye RD, Xu Y, Zhao Q, Wu B. Nat Commun 11 1208 (2020)
  13. In vitro expression and analysis of the 826 human G protein-coupled receptors. Lv X, Liu J, Shi Q, Tan Q, Wu D, Skinner JJ, Walker AL, Zhao L, Gu X, Chen N, Xue L, Si P, Zhang L, Wang Z, Katritch V, Liu ZJ, Stevens RC. Protein Cell 7 325-337 (2016)
  14. Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Luginina A, Gusach A, Marin E, Mishin A, Brouillette R, Popov P, Shiriaeva A, Besserer-Offroy É, Longpré JM, Lyapina E, Ishchenko A, Patel N, Polovinkin V, Safronova N, Bogorodskiy A, Edelweiss E, Hu H, Weierstall U, Liu W, Batyuk A, Gordeliy V, Han GW, Sarret P, Katritch V, Borshchevskiy V, Cherezov V. Sci Adv 5 eaax2518 (2019)
  15. Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode. Shiimura Y, Horita S, Hamamoto A, Asada H, Hirata K, Tanaka M, Mori K, Uemura T, Kobayashi T, Iwata S, Kojima M. Nat Commun 11 4160 (2020)
  16. Critical nucleation size in the folding of small apparently two-state proteins. Bai Y, Zhou H, Zhou Y. Protein Sci 13 1173-1181 (2004)
  17. Crystal structure of the human 5-HT1B serotonin receptor bound to an inverse agonist. Yin W, Zhou XE, Yang D, de Waal PW, Wang M, Dai A, Cai X, Huang CY, Liu P, Wang X, Yin Y, Liu B, Zhou Y, Wang J, Liu H, Caffrey M, Melcher K, Xu Y, Wang MW, Xu HE, Jiang Y. Cell Discov 4 12 (2018)
  18. Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone. Im D, Inoue A, Fujiwara T, Nakane T, Yamanaka Y, Uemura T, Mori C, Shiimura Y, Kimura KT, Asada H, Nomura N, Tanaka T, Yamashita A, Nango E, Tono K, Kadji FMN, Aoki J, Iwata S, Shimamura T. Nat Commun 11 6442 (2020)
  19. Efficient sampling in fragment-based protein structure prediction using an estimation of distribution algorithm. Simoncini D, Zhang KY. PLoS One 8 e68954 (2013)
  20. Prediction of disulfide bond engineering sites using a machine learning method. Gao X, Dong X, Li X, Liu Z, Liu H. Sci Rep 10 10330 (2020)
  21. Prospects for de novo phasing with de novo protein models. Das R, Baker D. Acta Crystallogr D Biol Crystallogr 65 169-175 (2009)
  22. Structural basis of FPR2 in recognition of Aβ42 and neuroprotection by humanin. Zhu Y, Lin X, Zong X, Han S, Wang M, Su Y, Ma L, Chu X, Yi C, Zhao Q, Wu B. Nat Commun 13 1775 (2022)
  23. Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870. Zhou Y, Cao C, He L, Wang X, Zhang XC. Elife 8 e48822 (2019)
  24. Dimeric structures of quinol-dependent nitric oxide reductases (qNORs) revealed by cryo-electron microscopy. Gopalasingam CC, Johnson RM, Chiduza GN, Tosha T, Yamamoto M, Shiro Y, Antonyuk SV, Muench SP, Hasnain SS. Sci Adv 5 eaax1803 (2019)
  25. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability. Shi W, Wang L, Zhou T, Sastry M, Yang ES, Zhang Y, Chen M, Chen X, Choe M, Creanga A, Leung K, Olia AS, Pegu A, Rawi R, Schön A, Shen CH, Stancofski ED, Talana CA, Teng IT, Wang S, Corbett KS, Tsybovsky Y, Mascola JR, Kwong PD. Structure 30 1233-1244.e7 (2022)
  26. Identification of natural products as novel ligands for the human 5-HT2C receptor. Peng Y, Zhao S, Wu Y, Cao H, Xu Y, Liu X, Shui W, Cheng J, Zhao S, Shen L, Ma J, Quinn RJ, Stevens RC, Zhong G, Liu ZJ. Biophys Rep 4 50-61 (2018)
  27. Molecular mechanism of agonism and inverse agonism in ghrelin receptor. Qin J, Cai Y, Xu Z, Ming Q, Ji SY, Wu C, Zhang H, Mao C, Shen DD, Hirata K, Ma Y, Yan W, Zhang Y, Shao Z. Nat Commun 13 300 (2022)
  28. Increasing the Stability of Recombinant Human Green Cone Pigment. Owen TS, Salom D, Sun W, Palczewski K. Biochemistry 57 1022-1030 (2018)
  29. Structural basis for recognition of antihistamine drug by human histamine receptor. Peng X, Yang L, Liu Z, Lou S, Mei S, Li M, Chen Z, Zhang H. Nat Commun 13 6105 (2022)
  30. Enhancing fragment-based protein structure prediction by customising fragment cardinality according to local secondary structure. Abbass J, Nebel JC. BMC Bioinformatics 21 170 (2020)
  31. Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1. Ou L, Gulla K, Biju A, Biner DW, Bylund T, Changela A, Chen SJ, Zheng CY, Cibelli N, Corrigan AR, Duan H, Gonelli CA, Kong WP, Cheng C, O'Dell S, Sarfo EK, Shaddeau A, Wang S, Vinitsky A, Yang Y, Zhang B, Zhang Y, Koup RA, Doria-Rose NA, Gall JG, Mascola JR, Kwong PD. Vaccines (Basel) 10 1916 (2022)
  32. Structural insight into an anti-BRIL Fab as a G-protein-coupled receptor crystallization chaperone. Miyagi H, Suzuki M, Yasunaga M, Asada H, Iwata S, Saito JI. Acta Crystallogr D Struct Biol 79 435-441 (2023)
  33. Structural insights into the human niacin receptor HCA2-Gi signalling complex. Yang Y, Kang HJ, Gao R, Wang J, Han GW, DiBerto JF, Wu L, Tong J, Qu L, Wu Y, Pileski R, Li X, Zhang XC, Zhao S, Kenakin T, Wang Q, Stevens RC, Peng W, Roth BL, Rao Z, Liu ZJ. Nat Commun 14 1692 (2023)


Reviews citing this publication (9)

  1. A new generation of protein display scaffolds for molecular recognition. Hosse RJ, Rothe A, Power BE. Protein Sci 15 14-27 (2006)
  2. GPCR crystal structures: Medicinal chemistry in the pocket. Shonberg J, Kling RC, Gmeiner P, Löber S. Bioorg Med Chem 23 3880-3906 (2015)
  3. Designing proteins from the inside out. Ventura S, Serrano L. Proteins 56 1-10 (2004)
  4. Novel forms of chemical protein diversity -- in nature and in the laboratory. Kent S. Curr Opin Biotechnol 15 607-614 (2004)
  5. Combinatorial approaches to protein stability and structure. Magliery TJ, Regan L. Eur J Biochem 271 1595-1608 (2004)
  6. Selection of stably folded proteins by phage-display with proteolysis. Bai Y, Feng H. Eur J Biochem 271 1609-1614 (2004)
  7. Advancements in therapeutically targeting orphan GPCRs. Stockert JA, Devi LA. Front Pharmacol 6 100 (2015)
  8. Phage display--a powerful technique for immunotherapy: 2. Vaccine delivery. Bazan J, Całkosiński I, Gamian A. Hum Vaccin Immunother 8 1829-1835 (2012)
  9. Molecular diversity in engineered protein libraries. Barakat NH, Love JJ. Curr Opin Chem Biol 11 335-341 (2007)

Articles citing this publication (29)

  1. Molecular control of δ-opioid receptor signalling. Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, Cherezov V, Roth BL, Stevens RC. Nature 506 191-196 (2014)
  2. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, Huang XP, Trapella C, Guerrini R, Calo G, Roth BL, Cherezov V, Stevens RC. Nature 485 395-399 (2012)
  3. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, Cale EM, Chen L, Choi CW, Chuang GY, Doria-Rose NA, Druz A, Georgiev IS, Gorman J, Huang J, Joyce MG, Louder MK, Ma X, McKee K, O'Dell S, Pancera M, Yang Y, Blanchard SC, Mothes W, Burton DR, Koff WC, Connors M, Ward AB, Kwong PD, Mascola JR. Science 352 828-833 (2016)
  4. Fractional 13C enrichment of isolated carbons using [1-13C]- or [2- 13C]-glucose facilitates the accurate measurement of dynamics at backbone Calpha and side-chain methyl positions in proteins. Lundström P, Teilum K, Carstensen T, Bezsonova I, Wiesner S, Hansen DF, Religa TL, Akke M, Kay LE. J Biomol NMR 38 199-212 (2007)
  5. D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Wang S, Wacker D, Levit A, Che T, Betz RM, McCorvy JD, Venkatakrishnan AJ, Huang XP, Dror RO, Shoichet BK, Roth BL. Science 358 381-386 (2017)
  6. A protein folding pathway with multiple folding intermediates at atomic resolution. Feng H, Zhou Z, Bai Y. Proc Natl Acad Sci U S A 102 5026-5031 (2005)
  7. Structural basis for bifunctional peptide recognition at human δ-opioid receptor. Fenalti G, Zatsepin NA, Betti C, Giguere P, Han GW, Ishchenko A, Liu W, Guillemyn K, Zhang H, James D, Wang D, Weierstall U, Spence JC, Boutet S, Messerschmidt M, Williams GJ, Gati C, Yefanov OM, White TA, Oberthuer D, Metz M, Yoon CH, Barty A, Chapman HN, Basu S, Coe J, Conrad CE, Fromme R, Fromme P, Tourwé D, Schiller PW, Roth BL, Ballet S, Katritch V, Stevens RC, Cherezov V. Nat Struct Mol Biol 22 265-268 (2015)
  8. Probing the high energy states in proteins by proteolysis. Park C, Marqusee S. J Mol Biol 343 1467-1476 (2004)
  9. Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine. Kimura KT, Asada H, Inoue A, Kadji FMN, Im D, Mori C, Arakawa T, Hirata K, Nomura Y, Nomura N, Aoki J, Iwata S, Shimamura T. Nat Struct Mol Biol 26 121-128 (2019)
  10. Computational design and selections for an engineered, thermostable terpene synthase. Diaz JE, Lin CS, Kunishiro K, Feld BK, Avrantinis SK, Bronson J, Greaves J, Saven JG, Weiss GA. Protein Sci 20 1597-1606 (2011)
  11. In silico protein design by combinatorial assembly of protein building blocks. Tsai HH, Tsai CJ, Ma B, Nussinov R. Protein Sci 13 2753-2765 (2004)
  12. Detection and structure determination of an equilibrium unfolding intermediate of Rd-apocytochrome b562: native fold with non-native hydrophobic interactions. Feng H, Vu ND, Bai Y. J Mol Biol 343 1477-1485 (2004)
  13. Crystal structure of the endogenous agonist-bound prostanoid receptor EP3. Morimoto K, Suno R, Hotta Y, Yamashita K, Hirata K, Yamamoto M, Narumiya S, Iwata S, Kobayashi T. Nat Chem Biol 15 8-10 (2019)
  14. Structure of a human intramembrane ceramidase explains enzymatic dysfunction found in leukodystrophy. Vasiliauskaité-Brooks I, Healey RD, Rochaix P, Saint-Paul J, Sounier R, Grison C, Waltrich-Augusto T, Fortier M, Hoh F, Saied EM, Arenz C, Basu S, Leyrat C, Granier S. Nat Commun 9 5437 (2018)
  15. An on-pathway hidden intermediate and the early rate-limiting transition state of Rd-apocytochrome b562 characterized by protein engineering. Zhou Z, Huang Y, Bai Y. J Mol Biol 352 757-764 (2005)
  16. An efficient, step-economical strategy for the design of functional metalloproteins. Rittle J, Field MJ, Green MT, Tezcan FA. Nat Chem 11 434-441 (2019)
  17. Structure of the human marker of self 5-transmembrane receptor CD47. Fenalti G, Villanueva N, Griffith M, Pagarigan B, Lakkaraju SK, Huang RY, Ladygina N, Sharma A, Mikolon D, Abbasian M, Johnson J, Hadjivassiliou H, Zhu D, Chamberlain PP, Cho H, Hariharan K. Nat Commun 12 5218 (2021)
  18. Molecular basis of tail-anchored integral membrane protein recognition by the cochaperone Sgt2. Lin KF, Fry MY, Saladi SM, Clemons WM. J Biol Chem 296 100441 (2021)
  19. Fold helical proteins by energy minimization in dihedral space and a DFIRE-based statistical energy function. Li H, Zhou Y. J Bioinform Comput Biol 3 1151-1170 (2005)
  20. Probing the folding intermediate of Rd-apocyt b562 by protein engineering and infrared T-jump. Wang T, Zhou Z, Bunagan MR, Du D, Bai Y, Gai F. Protein Sci 16 1176-1183 (2007)
  21. Repacking of hydrophobic residues in a stable mutant of apocytochrome b562 selected by phage-display and proteolysis. Feng H, Bai Y. Proteins 56 426-429 (2004)
  22. Structural basis for assembly and lipid-mediated gating of LRRC8A:C volume-regulated anion channels. Kern DM, Bleier J, Mukherjee S, Hill JM, Kossiakoff AA, Isacoff EY, Brohawn SG. Nat Struct Mol Biol 30 841-852 (2023)
  23. The active form of quinol-dependent nitric oxide reductase from Neisseria meningitidis is a dimer. Jamali MAM, Gopalasingam CC, Johnson RM, Tosha T, Muramoto K, Muench SP, Antonyuk SV, Shiro Y, Hasnain SS. IUCrJ 7 404-415 (2020)
  24. Cannabinoid receptor interacting protein 1a interacts with myristoylated Gαi N terminus via a unique gapped β-barrel structure. Booth WT, Clodfelter JE, Leone-Kabler S, Hughes EK, Eldeeb K, Howlett AC, Lowther WT. J Biol Chem 297 101099 (2021)
  25. Computationally Guided Redesign of a Heme-free Cytochrome with Native-like Structure and Stability. Hoffnagle AM, Eng VH, Markel U, Tezcan FA. Biochemistry 61 2063-2072 (2022)
  26. State-Targeting Stabilization of Adenosine A2A Receptor by Fusing a Custom-Made De Novo Designed α-Helical Protein. Mitsumoto M, Sugaya K, Kazama K, Nakano R, Kosugi T, Murata T, Koga N. Int J Mol Sci 22 12906 (2021)
  27. Crystal structure of adenosine A2A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction. Claff T, Schlegel JG, Voss JH, Vaaßen VJ, Weiße RH, Cheng RKY, Markovic-Mueller S, Bucher D, Sträter N, Müller CE. Commun Chem 6 106 (2023)
  28. Crystal structure of the membrane (M) protein from a bat betacoronavirus. Wang X, Yang Y, Sun Z, Zhou X. PNAS Nexus 2 pgad021 (2023)
  29. E. coli Expression and Purification of Microbial and Viral Rhodopsins. Balandin T, Volkov D, Alekseev A, Kovalev K, Bratanov D, Gordeliy V. Methods Mol Biol 2501 109-124 (2022)


Quick links